Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance, comparing...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels.

Oncology and therapy·2026
Same author

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same author

Childhood trauma, emotions, and the eating disorder voice.

Journal of eating disorders·2026
Same author

Cerebrospinal Fluid Findings among Patients with Anaplasmosis and Central Nervous Involvement, Minnesota and Wisconsin, USA.

Emerging infectious diseases·2026
Same author

Co-expression of superoxide and peroxide scavenging antioxidant enzymes rescues β cells from hypoxia and hyperglycemia-induced oxidative damage.

Tissue & cell·2026
Same author

The effect of elbow posture on biceps function at the shoulder in brachial plexus birth injuries: A computational sensitivity analysis.

Clinical biomechanics (Bristol, Avon)·2026
Same journal

A Hybrid FMEA-AHP Framework for Risk Prioritization in Nontransparent Artificial Intelligence Systems.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Trust-Building Communication for Extreme Heat Preparedness.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Spring Broken: A Risk Analysis of Fatal and Nonfatal Traffic Injuries in Florida.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Global Sensitivity Analysis of Societal Resilience Using Shapley Values and Polynomial Chaos Expansion.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Assessing How Fact-Checks Influence Accuracy and Consensus Judgments: Evidence From the Olympics.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Applying the Bow Tie Method to Evaluate Emerging Risk: The Case of Carbon Capture and Water Stress.

Risk analysis : an official publication of the Society for Risk Analysis·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Nonparametric Bayesian methods for benchmark dose estimation.

Nilabja Guha1, Anindya Roy, Leonid Kopylev

  • 1Department of Mathematics and Statistics, University of Maryland Baltimore County, Baltimore, MD, USA.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|January 24, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces two Bayesian nonparametric methods for benchmark dose estimation in animal toxicology studies. These flexible approaches offer improved model fitting, especially when traditional methods fail.

Keywords:
BMDLBMDS softwaredirichlet distributionintegrated Brownian motion

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Related Experiment Videos

Last Updated: May 14, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Area of Science:

  • Toxicology
  • Biostatistics
  • Computational Biology

Background:

  • Benchmark dose (BMD) estimation is crucial for risk assessment in toxicology.
  • Traditional parametric models in benchmark dose estimation software (BMDS) may not adequately fit all dose-response data.
  • Nonparametric methods offer potential for greater flexibility in modeling complex biological responses.

Purpose of the Study:

  • To propose and evaluate two Bayesian nonparametric estimation procedures for benchmark dose estimation.
  • To compare the performance of these new methods against existing parametric and nonparametric approaches.
  • To assess the utility of Bayesian nonparametric methods when standard models fail to fit toxicological data.

Main Methods:

  • Development and application of two Bayesian nonparametric estimation procedures.
  • Illustration using existing animal dose-response datasets.
  • Comparative analysis with standard benchmark dose estimation software (BMDS) parametric methods.
  • Comparison with published model-averaging and frequentist nonparametric approaches.
  • Performance evaluation through simulation studies.

Main Results:

  • Bayesian nonparametric methods demonstrate significant flexibility in model fitting for dose-response data.
  • These methods provide a viable alternative when standard parametric models exhibit inadequate fit.
  • Simulations and data set analyses confirm the utility of the proposed procedures.

Conclusions:

  • Bayesian nonparametric estimation offers a powerful and flexible tool for benchmark dose estimation.
  • These methods enhance the reliability of toxicological risk assessment, particularly for challenging datasets.
  • The proposed procedures represent a valuable advancement in benchmark dose estimation methodology.